Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
life sciences
national blog main
san francisco blog main
san francisco top stories
biotech
boston blog main
new york blog main
new york top stories
sanofi
startups
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
biontech
bluerock therapeutics
boehringer ingelheim
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
curevac
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
eli lilly
What
bio
3
×
deal
3
×
medicines
ability
acquire
acquisitions
announced
array
babies
bets
business
cancer
ceo
collabs
comes
companies
cost
covid
cut
daniel
date
effective
enticed
evidence
expand
genetic
gilead
gilead’s
hasn’t
help
introduce
invitae
ipo
latest
low
maker
medical
messenger
molecules
month
Language
unset
Current search:
bio
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Invitae Offers $55M for Singular Bio to Expand Prenatal Test Business
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines